The POBOY Study vs PPF 2023

This is the app for the Prevention Of Bleeding by Optimizing prophYlaxis study. Your use of the app creates a valuable record that may allow us to develop an optimal administration regimen for the prophylactic treatment of hemophilia and better understand what causes breakthrough bleeding. Use the app to record and review your own daily activities, infusions, and bleeds. The app also allows you to easily keep up with your own care as well by allowing you to see what you've taken and when. Quickly scan the boxes of your factor or other product to record when you take anti-hemophilic medications. The app supports automated scanning of many products that contain these clotting factors/medications: - Clotting Factor VIII - Clotting Factor IX - Hemlibra - Von Willebrand Factor - Activated Factor VII Sign up using the welcome letter you received from the University of Colorado Hemophilia and Thrombosis Center.

The Plasma Protein Forum (PPF) is the premier conference for the plasma protein therapeutics industry in North America. This annual event brings industry, policymakers, health care providers, scientists, and patients together to learn more about and discuss key developments and issues. The 2023 PPF will be held November 14-15 in Washington, D.C. The PPF is organized by the Plasma Protein Therapeutics Association (PPTA), a dynamic trade association that represents a unique sector of the biologics and biotechnology industry. PPTA represents more than 1,000 human plasma collection centers in North America and Europe, as well as the manufacturers of lifesaving plasma protein therapies. Our members produce approximately 80% of the plasma protein therapies in the U.S. and 60% of those manufactured in Europe. PPTA works globally to: advocate for access to and affordability of therapies for patients, engage in constructive dialogue with regulatory agencies, and collaborate with patient advocacy organizations.